دورية أكاديمية
Acceptance and willingness to purchase a hypothetical COVID-19 vaccine in a region under Shariah law: A cross-sectional study in Aceh, Indonesia.
| العنوان: | Acceptance and willingness to purchase a hypothetical COVID-19 vaccine in a region under Shariah law: A cross-sectional study in Aceh, Indonesia. |
|---|---|
| المؤلفون: | Rayhan MA; School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia., Mudatsir M; Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia., Nurjannah N; Department of Public Health, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia., Ichsan I; Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.; Tsunami and Disaster Mitigation Research Center (TDMR), Universitas Syiah Kuala, Banda Aceh, Indonesia., Amir-Behghadami M; Iranian Center of Excellence in Health Management, Department of Health Service Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran., Khader YS; Jordan University of Science and Technology, Irbid, Jordan., Koyanagi A; Research and Development Unit, Parc Sanitari Sant Joan de Déu, ICREA, CIBERSAM, ISCIII, Barcelona, Spain., Sah R; Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu Nepal., Viveiros-Rosa SG; Pharmacy Division, Instituto Nacional da Propriedade Industrial, Rio de Janeiro, Rio de Janeiro, Brazil., Mamun MA; Department of Public Health and Informatics, Jahangirnagar University, Dhaka, Bangladesh.; CHINTA Research Bangladesh, Dhaka, Bangladesh., Lemu YK; Department of Health, Behavior and Society, Faculty of Public Health, Jimma University, Ethiopia., Bouchra A; National School of Public Health, Rabat, Morocco., Linguissi LS; Institut National de Recherche en Science de la Santé, Brazzaville, Republique of Congo., Ikram A; National Institutes of Health, Islamabad, Pakistan., Sallam DE; Pediatrics and Pediatric Nephrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Parperis K; Department of Internal Medicine, University of Cyprus Medical School, Nicosia, Cyprus., Wollina U; Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany., Rademaker M; Clinical Trials New Zealand, Hamilton, New Zealand., Vento S; Faculty of Medicine, University of Puthisastra, Phnom Penh, Cambodia., Usman S; Department of Public Health, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia. |
| المصدر: | Narra J [Narra J] 2022 Aug; Vol. 2 (2), pp. e85. Date of Electronic Publication: 2022 Aug 01. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Narra Sains Indonesia Country of Publication: Indonesia NLM ID: 9918625888906676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2807-2618 (Electronic) Linking ISSN: 28072618 NLM ISO Abbreviation: Narra J Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Banda Aceh, Indonesia : Narra Sains Indonesia, [2021]- |
| مستخلص: | Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to determine the acceptance of and willingness to purchase a hypothetical COVID-19 vaccine in the general population of Aceh, a holistic Shariah law implementation province in Indonesia. An online cross-sectional study was conducted using a quota sampling technique between 1 to 24 September 2021. To determine hypothetical vaccine acceptance, respondents were asked if they were willing to accept vaccines with combinations of either 50% or 95% effectiveness and either 5% or 20% risk of adverse effects. Willingness to purchase was assessed by asking whether the participants would pay for such vaccines at certain price points. Logistic regression analysis was used to assess the associated determinants. Out of 377 respondents included in the final analysis, 86.5% were willing to accept a COVID-19 vaccine with 95% effectiveness and 5% adverse effects. The acceptance rate dropped to 45.1% if the risk of adverse effects was 20%. Vaccines with 50% effectiveness and 5% adverse effects were acceptable to 42.2% but the acceptance went down to 17.2% if the risk of adverse effects increased to 20%. Multivariate analysis found that men were twice as likely to accept a vaccine with 95% effectiveness and 5% adverse effects compared to females (aOR: 2.01; 95% CI 1.05-3.86). We found that 156/377 (41.3%) of respondents were willing to purchase a COVID-19 vaccine and of these participants 71.1% were willing to pay between Indonesian Rupiah (IDR) 50,000-150,000 (US$ 3.33-10.00). In conclusion, the acceptance rate of a hypothetical COVID-19 vaccine varied based on effectiveness and the risk of adverse effects. Competing Interests: All the authors declare that there are no conflicts of interest. (© 2022 The Author(s).) |
| References: | Sci Transl Med. 2020 Nov 4;12(568):. (PMID: 33077678) Vaccines (Basel). 2021 Sep 11;9(9):. (PMID: 34579247) Travel Med Infect Dis. 2020 Mar - Apr;34:101623. (PMID: 32179124) Clin Microbiol Rev. 2020 Jun 24;33(4):. (PMID: 32580969) J Med Internet Res. 2021 Jan 15;23(1):e26089. (PMID: 33400682) Health Expect. 2020 Dec;23(6):1543-1578. (PMID: 33022806) Vaccine. 2021 Apr 1;39(14):1968-1976. (PMID: 33714653) Vaccine. 2020 Sep 29;38(42):6500-6507. (PMID: 32863069) Hum Vaccin Immunother. 2020 Sep 1;16(9):2204-2214. (PMID: 32730103) PLoS One. 2021 Sep 9;16(9):e0257096. (PMID: 34499673) Soc Sci Med. 2021 Mar;272:113642. (PMID: 33414031) Vaccine. 2020 Dec 3;38(51):8090-8098. (PMID: 33187765) Hum Vaccin Immunother. 2020 Dec 1;16(12):3074-3080. (PMID: 32991230) Front Public Health. 2020 Jul 14;8:381. (PMID: 32760691) Vaccines (Basel). 2021 Jan 18;9(1):. (PMID: 33477725) Vaccines (Basel). 2022 May 08;10(5):. (PMID: 35632492) Vaccines (Basel). 2020 Aug 27;8(3):. (PMID: 32867224) JAMA. 2020 Nov 24;324(20):2095-2096. (PMID: 33074293) Vaccines (Basel). 2021 Oct 09;9(10):. (PMID: 34696264) J Multidiscip Healthc. 2020 Nov 20;13:1657-1663. (PMID: 33262600) J Hosp Infect. 2021 Feb;108:168-173. (PMID: 33259883) Vaccines (Basel). 2021 May 02;9(5):. (PMID: 34063182) Eur J Health Econ. 2020 Sep;21(7):977-982. (PMID: 32591957) Vaccine. 2017 May 15;35(21):2823-2830. (PMID: 28412075) Appl Health Econ Health Policy. 2021 Nov;19(6):871-883. (PMID: 34608611) |
| فهرسة مساهمة: | Keywords: Acceptance; COVID-19; Syariah law; vaccine; willingness to purchase |
| تواريخ الأحداث: | Date Created: 20240307 Latest Revision: 20240308 |
| رمز التحديث: | 20240308 |
| مُعرف محوري في PubMed: | PMC10914119 |
| DOI: | 10.52225/narra.v2i2.85 |
| PMID: | 38449698 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2807-2618 |
|---|---|
| DOI: | 10.52225/narra.v2i2.85 |